Detalhe da pesquisa
1.
Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
Ann Rheum Dis
; 81(5): 653-661, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35264321
2.
Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors.
Oncologist
; 26(4): e622-e631, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33301227
3.
Avapritinib in Patients With Advanced Gastrointestinal Stromal Tumors Following at Least Three Prior Lines of Therapy.
Oncologist
; 26(4): e639-e649, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33453089
4.
Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial.
Lancet Oncol
; 21(7): 935-946, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32615108
5.
Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial.
Eur J Cancer
; 145: 132-142, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33465704